Literature DB >> 31799699

Role of telomerase in the tumour microenvironment.

Ning Liu1, Xue-Hua Guo1, Jun-Ping Liu2, Yu-Sheng Cong2,3.   

Abstract

Telomeres are specialized genomic structures that protect chromosomal ends to maintain genomic stability. Telomeric length is primarily regulated by the telomerase complex, essentially consisting of an RNA template (TERC), an enzymatic subunit (telomerase reverse transcriptase, TERT). In humans, telomerase activity is repressed during embryonic differentiation and is absent in most somatic cells. However, it is upregulated or reactivated in 80%-90% of the primary tumours in humans. The human TERT (hTERT) plays a pivotal role in cellular immortality and tumourigenesis. However, the molecular mechanisms of telomerase functioning in cancer have not been fully understood beyond the telomere maintenance. Several research groups, including ours, have demonstrated that hTERT possesses vital functions independent of its telomere maintenance, including angiogenesis, inflammation, cancer cell stemness, and epithelial-mesenchymal transformation (EMT). All these telomere-independent activities of hTERT may contribute to the regulation of the dynamics and homeostasis of the tumour microenvironment (TME), thereby promoting tumour growth and development. Cancer progression and metastasis largely depend upon the interactions between cancer cells and their microenvironment. In this review, the involvement of TERT in the tumour microenvironment and the underlying implications in cancer therapeutics have been summarized.
© 2019 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  TERT; angiogenesis; inflammation; telomerase; tumour microenvironment

Mesh:

Substances:

Year:  2019        PMID: 31799699     DOI: 10.1111/1440-1681.13223

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

1.  The association of telomere maintenance and TERT expression with susceptibility to human papillomavirus infection in cervical epithelium.

Authors:  Li-Na Wang; Li Wang; Guanghui Cheng; Mingkai Dai; Yunhai Yu; Guoxin Teng; Jingjie Zhao; Dawei Xu
Journal:  Cell Mol Life Sci       Date:  2022-01-31       Impact factor: 9.261

2.  MAPK/ERK-CBP-RFPL-3 Mediates Adipose-Derived Stem Cell-Induced Tumor Growth in Breast Cancer Cells by Activating Telomerase Reverse Transcriptase Expression.

Authors:  Wenjie Li; Cheng Qian; Fei Ma; Meng Liu; Xiaojun Sun; Xu Liu; Chunxiao Liu; Zhenghua Chen; Weichang Ma; Jian Liu; Haiqian Xu; Zhenlin Yang
Journal:  Stem Cells Int       Date:  2022-06-07       Impact factor: 5.131

Review 3.  Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.

Authors:  Seung Wan Son; Han Yeoung Lee; Sokviseth Moeng; Hyo Jeong Kuh; Soo Young Choi; Jong Kook Park
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

Review 4.  Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?

Authors:  Amir Barzegar Behrooz; Amir Syahir
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

Review 5.  Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis.

Authors:  Xiaojing Hong; Lihui Wang; Kexiong Zhang; Jun Liu; Jun-Ping Liu
Journal:  Cells       Date:  2022-03-03       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.